Provided by Tiger Trade Technology Pte. Ltd.

Hims & Hers Health Inc.

29.58
+0.74002.57%
Post-market: 29.54-0.0400-0.14%16:08 EDT
Volume:7.95M
Turnover:233.77M
Market Cap:6.90B
PE:-47.48
High:29.79
Open:28.67
Low:28.63
Close:28.84
52wk High:65.30
52wk Low:13.74
Shares:233.31M
Float Shares:212.45M
Volume Ratio:0.67
T/O Rate:3.74%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6230
EPS(LYR):0.5123
ROE:-32.03%
ROA:-2.21%
PB:21.30
PE(LYR):57.74

Loading ...

Movement Alert|Hims & Hers Health Inc. Rises 6.69% in Regular Trading, FDA Peptide Drug Access Advocacy Gains Market Approval

Market Focus
·
Jul 24

Hims & Hers Shares up 2% After Telehealth Firm Urged FDA to Broaden Access to Some Peptides in Panel Meeting

THOMSON REUTERS
·
Jul 23

Peptides Could Soon Become Widely Available in the U.S. Here's What Happens Next.

Dow Jones
·
Jul 23

Hims & Hers Health Inc : Citigroup Raises Target Price to $35 from $28

THOMSON REUTERS
·
Jul 23

Hims & Hers CFO Oluyemi Okupe Disposes of 7,163 Common Shares Valued at $229,075.99

Reuters
·
Jul 21

Trump's FDA May Soon Back Peptides. Should You Buy In?

Dow Jones
·
Jul 18

Hims & Hers Accounting Chief Exits

Dow Jones
·
Jul 18

Hims & Hers Chief Accounting Officer, Irene Becklund, Announces Departure from the Company

THOMSON REUTERS
·
Jul 18

Movement Alert|Hims & Hers Health Falls 5.05% in Regular Trading, Trading at $32.87

Market Focus
·
Jul 17

Cboe data shows mixed options sentiment in Hims and Hers Health with shares down 9.35%

TIPRANKS
·
Jul 17

Movement Alert|Hims & Hers Health Declines 5.3% in Regular Trading, Trading at $36.04

Market Focus
·
Jul 16

Movement Alert|Hims & Hers Health Rises 5.26% in Regular Trading, Trading at $36.85

Market Focus
·
Jul 15

Press Release: Hims & Hers to Announce Second Quarter 2026 Financial Results on August 10, 2026

Dow Jones
·
Jul 14

Hims & Hers Sets Second-quarter Results Release and Investor Call

Reuters
·
Jul 14

Movement Alert|Hims & Hers Health Falls 5.36% in Regular Trading, Insider Selling Filings Add to Ongoing Fundamental Pressure

Market Focus
·
Jul 10

Hims & Hers's Peptide Opportunity Remains in Focus

Dow Jones
·
Jul 10

Hims & Hers Health is Maintained at Neutral by B of a Securities

Dow Jones
·
Jul 09

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS) and Tarsus Pharmaceuticals (TARS)

TIPRANKS
·
Jul 09

Movement Alert|Hims & Hers Health Falls 5.11% in Regular Trading, Trading at $34.26

Market Focus
·
Jul 08

Movement Alert|Hims & Hers Health Falls 5.2% in Pre-Market Trading, Trading at $34.45

Market Focus
·
Jul 08